Stroma-contact prevents loss of hematopoietic stem cell quality during ex vivo expansion of CD34+ mobilized peripheral blood stem cells

Blood

Volumn 91, Issue 1, 1998, Pages 111-117

  Breems, Dimitri A ^a   Blokland, Ellen A W ^a   Siebel, Karen E ^a   Mayen, Angelique E M ^a   Engels, Lilian J A ^a   Ploemacher, Rob E ^a  

^a ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CYTOKINE; INTERLEUKIN 3; INTERLEUKIN 6; RECOMBINANT GRANULOCYTE COLONY STIMULATING FACTOR; THROMBOPOIETIN;

ARTICLE; AUTOTRANSPLANTATION; CELL CONTACT; CELL CULTURE; CELL MOTILITY; CELL SUBPOPULATION; CLINICAL ARTICLE; CULTURE MEDIUM; GRAFT FAILURE; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; LEUKAPHERESIS; PRIORITY JOURNAL; STEM CELL; STROMA;

EID: 0031975885     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.1.111     Document Type: Article

References (33)

1. Körbling M, Dörken B, Ho AD, Pezzutto A, Hunstein W, Fliedner TM: Autologous transplantation of blood-derived hemopoietic stem cells after myeloablative therapy in a patient with Burkitt's lymphoma. Blood 67:529, 1986
2. Kessinger A, Armitage JO, Landmark JD, Weisenburger DD: Reconstitution of human hematopoietic function with autologous cryopreserved circulating stem cells. Exp Hematol 14:192, 1986
3. Reiffers J, Bernard P, David B, Vezon G, Sarrat A, Marit G, Moulinier J, Broustet A: Successful autologous transplantation with peripheral blood hemopoietic cells in a patient with acute leukemia. Exp Hematol 14:312, 1986
4. Brugger W, Heimfeld S, Berenson RJ, Mertelsmann R, Kanz L: Reconstitution of hematopoiesis after high-dose chemotherapy by autologous progenitor cells generated ex vivo. N Eng J Med 333:283, 1995
5. Williams SF, Lee WJ, Bender JG, Zimmerman T, Swinney P, Blake M, Carreon J, Schilling M, Smith S, Williams DE, Oldham F, Van Epps D: Selection and expansion of peripheral blood CD34+ cells in autologous stem cell transplantation for breast cancer. Blood 87:1687, 1996
6. + cells isolated from cryopreserved peripheral-blood progenitor cells can be expanded ex vivo and used for transplantation with little or no toxicity. J Clin Oncol 14:1839, 1996
7. Henschler R, Brugger W, Luft T, Frey T, Mertelsmann R, Kanz L: Maintenance of transplantation potential in ex vivo expanded CD34+-selected human peripheral blood progenitor cells. Blood 84:2898, 1994
8. Van Zant G, Rummel SA, Koller MR, Larson DB, Drubachevsky I, Palsson M. Emerson SG: Expansion in bioreactors of human progenitor populations from cord blood and mobilized peripheral blood. Blood Cells 20:482, 1994
9. Sandstrom CE, Bender JG, Papoutsakis ET, Miller WM: Effects of CD34+ cell selection and perfusion on ex vivo expansion of peripheral blood mononuclear cells. Blood 86:958, 1995
10. Breems DA, Blokland EAW, Ploemacher RE: Stroma-conditioned media improve expansion of human primitive hematopoietic stem cells and progenitor cells. Leukemia 11:142, 1997
11. Peters SO, Kittler ELW, Ramshaw HS, Quesenberry PJ: Ex vivo expansion of murine marrow cells with interleukin-3 (IL-3), IL-6, IL-11, and stem cell factor leads to impaired engraftment in irradiated hosts. Blood 87:30, 1996
12. Holyoake TL, Freshney MG, McNair L, Parker AN, McKay PJ, Steward WP, Fitzsimons E, Graham GJ, Pragnell IB: Ex vivo expansion with stem cell factor and interleukin-11 augments both short-term recovery posttransplant and the ability to serially transplant marrow. Blood 87:4589, 1996
13. Van der Loo JCM, Ploemacher RE: Marrow- and spleen-seeding efficiencies of all murine hematopoietic stem cell subsets are decreased by preincubation with hematopoietic growth factors. Blood 85:2598, 1995
14. Breems DA, Van Hennik PB, Kuşadasi N, Boudewijn A, Cornelissen JJ, Sonneveld P, Ploemacher RE: Individual stem cell quality in leukapheresis products is related to the number of mobilized stem cells. Blood 87:5370, 1996
15. Van Hennik PB, Breems DA, Withagen CM, Slaper ICM, Ploemacher RE: Graft-failure can be predicted by testing the ability of stem cells to produce progenitors in long-term stroma-supported cultures. Exp Hematol 25:742, 1997 (abstr)
16. Dexter TM, Allen TD, Lajtha LG: Conditions controlling the proliferation of haemopoietic stem cells in vitro. J Cell Physiol 91:335, 1977
17. Gartner S, Kaplan HS: Long-term culture of human bone marrow cells. Proc Natl Acad Sci USA 77:4756, 1980
18. Breems DA, Blokland EAW, Neben S, Ploemacher RE: Frequency analysis of human primitive haematopoietic stem cell subsets using a cobblestone area forming cell assay. Leukemia 8:1095, 1994
19. Thalmeier K, Meissner P, Reisbach G, Falk M, Brechtel A, Dörmer P: Establishment of two permanent human bone marrow stromal cell lines with long-term post irradiation feeder capacity. Blood 83:1799, 1994
20. Verfaillie CM: Direct contact between human primitive hematopoietic progenitors and bone marrow stroma is not required for long-term in vitro hematopoiesis. Blood 79:2821, 1992
21. Verfaillie CM: Soluble factor(s) produced by human bone marrow stroma increase cytokine-induced proliferation and maturation of primitive hematopoietic progenitors while preventing their terminal differentiation. Blood 82:2045, 1993
22. Hurley RW, McCarthy JB, Verfaillie CM: Direct adhesion to bone marrow stroma via fibronectin receptors inhibits hematopoietic progenitor proliferation. J Clin Invest 96:511, 1995
23. Verfaillie CM, Catanzaro P: Direct contact with stroma inhibits proliferation of human long-term culture initiating cells. Leukemia 10:498, 1996
24. Verfaillie CM, Catanzarro PM, Li W-N: Macrophage inflammatory protein 1α, interleukin 3 and diffusible marrow stromal factors maintain human hematopoietic stem cells for at least eight weeks in vitro. J Exp Med 179:643, 1994
25. Koller MR, Palsson MA, Manchel I, Palsson BØ: Long-term culture-initiating cell expansion is dependent on frequent medium exchange combined with stromal and other accessory cell effects. Blood 86:1784, 1995
26. Koller MR, Manchel I, Brott DA, Palsson BØ: Donor-to-donor variability in the expansion potential of human bone marrow cells is reduced by accessory cells but not by soluble growth factors. Exp Hematol 24:1484, 1996
27. Thalmeier K, Meissner P, Reisbach G, Hültner L, Mortensen BT, Brechtel A, Oostendorp RAJ, Dörmer P: Constitutive and modulated cytokine expression in two permanent human bone marrow stromal cell lines. Exp Hematol 24:1, 1996
28. Zijlmans JMJM, Kleiverda K, Heemskerk DPM, Kluin PhM, Visser JWM, Willemze R, Fibbe WE: No role for committed progenitor cells in engraftment following transplantation of murine cytokine-mobilized blood cells. Blood 86:112a, 1995 (abstr, suppl 1)
29. Verfaillie CM, Miller JS: A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC. Blood 86:2137, 1995
30. Cashman JD, Eaves AC, Raines EW, Ross R, Eaves CJ: Mechanisms that regulate the cell cycle status of very primitive hematopoietic cells in long-term human marrow cultures. I. Stimulatory role of a variety of mesenchymal cell activators and inhibitory role of TGF-β. Blood 75:96, 1990
31. Koller MR, Bender JG, Miller WM, Papoutsakis ET: Expansion of primitive human hematopoietic progenitors in perfusion bioreactor system with IL-3, IL-6 and stem cell factor. Biotechnology 11:358, 1993
32. Petzer AL, Zandstra PW, Piret JM, Eaves CJ: Differential cytokine effects on primitive (CD34+CD38-) human hematopoietic cells: Novel responses to Flt3-ligand and thrombopoietin. J Exp Med 183:2551, 1996
33. Petzer AL, Hogge DE, Lansdorp PM, Reid DS, Eaves CJ: Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium. Proc Natl Acad Sci USA 93:1470, 1996